IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison Report
Performance
Performance Report
Concord Biotech IPO listing price is ₹ 941.85, issue price is ₹ 741.00, and currently trading at ₹ 1798.60 as on June 26, 2025. Concord Biotech IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Concord Biotech IPO is a Book Building listing on BSE,NSE exchange. The company is based in Ahmedabad and caters to Pharmaceutical sector. Citigroup Global Markets India , Jefferies India , Kotak Mahindra Capital Company are the merchant bankers of Concord Biotech IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 12th August 2022.
Concord Biotech IPO offer price is ₹ 741.00 and got listed at ₹ 941.85. Read Concord Biotech IPO details mentioned above.The IPO of Concord Biotech Limited was listed on 18th August 2023. As of today, Concord Biotech IPO is trading at ₹ 1798.60, compared to the previous day’s close of ₹ 1814.90. Read the report above for detailed IPO performance.
The issue price of Concord Biotech IPO was ₹ 741.00 per equity share.
Concord Biotech IPO was listed at ₹941.85 on the stock exchange on 18th August 2023. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of June 26, 2025, the current market price of Concord Biotech IPO is ₹ 1798.60.
The 52-week high for Concord Biotech IPO is ₹ 2664.00, while the 52-week low is ₹ 1345.00. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Concord Biotech IPO listed at ₹ 941.85 against the issue price of ₹ 741.00 per equity share, showing a listing day gain/loss of 200.85 (27.11%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Concord Biotech IPO stock moved from its listing price of ₹ 941.85 to the current price of ₹1798.60 per equity share, reflecting a change of 90.96% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Concord Biotech IPO issue date of 18th August 2023 and CMP of ₹1798.60, the estimated CAGR is approximately 60.96%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 1
Issue
Price :
₹ 741.00
Listing Price :
₹ 941.85
Previous Day Closing
₹ 1814.90
Concord Biotech IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Concord Biotech Financial Review Page
Merchant Banker(s) of Concord Biotech IPO: Citigroup Global Markets India Private Limited , Jefferies India Private Limited , Kotak Mahindra Capital Company Limited
Concord Biotech IPO subscription was 24.87 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Concord Biotech IPO listed at a listing price of 941.85 against the offer price of 741.00.
The current market price of Concord Biotech is 1798.60.
Why Us?
